Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


28.06.22 / Tradegate WKN: A1W7RL / Symbol: AERI / Name: Aerie Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Aerie Pharmaceuticals Inc. Stock

There is an upward development for Aerie Pharmaceuticals Inc. compared to yesterday, with an increase of €0.15 (1.950%).

Pros and Cons of Aerie Pharmaceuticals Inc. in the next few years

G***** c******* t* c**********
S********** s********
C******** o* t** e**********
M***** P*******
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Aerie Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Aerie Pharmaceuticals Inc. 1.950% 4.196% 47.525% -45.620% 18.254% - -
Kala Pharmaceuticals -2.900% -20.477% -16.781% -93.124% -71.587% - -
Clovis Oncology Inc. 58.920% 70.124% 289.938% -42.868% 14.336% -78.774% -96.634%
Epizyme Inc. 0.700% 62.286% 195.833% -80.250% -36.692% - -


Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer:
Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that Peter